Literature DB >> 31125639

High prevalence of colonisation with carbapenem-resistant Enterobacteriaceae among patients admitted to Vietnamese hospitals: Risk factors and burden of disease.

Dien M Tran1, Mattias Larsson2, Linus Olson2, Ngoc T B Hoang1, Ngai K Le3, Dung T K Khu3, Hung D Nguyen4, Tam V Vu5, Tinh H Trinh6, Thinh Q Le7, Phuong T T Phan8, Binh G Nguyen9, Nhung H Pham9, Bang H Mai10, Tuan V Nguyen10, Phuong T K Nguyen10, Nhan D Le11, Tuan M Huynh12, Le T Anh Thu13, Tran C Thanh14, Björn Berglund15, Lennart E Nilsson15, Elin Bornefall15, Le H Song10, Håkan Hanberger16.   

Abstract

BACKGROUND: Carbapenem-resistant Enterobacteriaceae (CRE) is an increasing problem worldwide, but particularly problematic in low- and middle-income countries (LMIC) due to limitations of resources for surveillance of CRE and infection prevention and control (IPC).
METHODS: A point prevalence survey (PPS) with screening for colonisation with CRE was conducted on 2233 patients admitted to neonatal, paediatric and adult care at 12 Vietnamese hospitals located in northern, central and southern Vietnam during 2017 and 2018. CRE colonisation was determined by culturing of faecal specimens on selective agar for CRE. Risk factors for CRE colonisation were evaluated. A CRE admission and discharge screening sub-study was conducted among one of the most vulnerable patient groups; infants treated at an 80-bed Neonatal ICU from March throughout June 2017 to assess CRE acquisition, hospital-acquired infection (HAI) and treatment outcome.
RESULTS: A total of 1165 (52%) patients were colonised with CRE, most commonly Klebsiella pneumoniae (n = 805), Escherichia coli (n = 682) and Enterobacter spp. (n = 61). Duration of hospital stay, HAI and treatment with a carbapenem were independent risk factors for CRE colonisation. The PPS showed that the prevalence of CRE colonisation increased on average 4.2% per day and mean CRE colonisation rates increased from 13% on the day of admission to 89% at day 15 of hospital stay. At the NICU, CRE colonisation increased from 32% at admission to 87% at discharge, mortality was significantly associated (OR 5·5, P < 0·01) with CRE colonisation and HAI on admission.
CONCLUSION: These data indicate that there is an epidemic spread of CRE in Vietnamese hospitals with rapid transmission to hospitalised patients.
Copyright © 2019 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  CRE; Carbapenem resistance enterobacteriaceae; Colonisation; HAI; Hospital acquired infections; Mortality

Year:  2019        PMID: 31125639     DOI: 10.1016/j.jinf.2019.05.013

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  24 in total

1.  Epidemiology and clinical characteristics of infection/colonization due to carbapenemase-producing Enterobacterales in neonatal patients.

Authors:  Jiansheng Wang; Yuanpeng Lv; Weiwei Yang; Peng Zhao; Changfu Yin
Journal:  BMC Microbiol       Date:  2022-07-12       Impact factor: 4.465

2.  Predictors of carbapenem-resistant Enterobacteriaceae (CRE) strains in patients with COVID-19 in the ICU ward: a retrospective case-control study.

Authors:  Nicoleta-Dorina Vlad; Roxana Carmen Cernat; Sorina Carp; Romelia Mitan; Andrei Dumitru; Codruța Nemet; Septimiu Voidăzan; Sorin Rugină; Irina-Magdalena Dumitru
Journal:  J Int Med Res       Date:  2022-10       Impact factor: 1.573

3.  Prevalence and Molecular Typing of Colistin-Resistant Pseudomonas aeruginosa (CRPA) Among β-Lactamase-Producing Isolates: A Study Based on High-Resolution Melting Curve Analysis Method.

Authors:  Hamed Tahmasebi; Sanaz Dehbashi; Mohammad Reza Arabestani
Journal:  Infect Drug Resist       Date:  2020-08-21       Impact factor: 4.003

4.  Dissemination of Carbapenemases (OXA-48, NDM and VIM) Producing Enterobacteriaceae Isolated from the Mohamed VI University Hospital in Marrakech, Morocco.

Authors:  Souad Loqman; Nabila Soraa; Seydina M Diene; Jean-Marc Rolain
Journal:  Antibiotics (Basel)       Date:  2021-04-26

5.  Gastrointestinal Carriage of Vancomycin-Resistant Enterococci and Carbapenem-Resistant Gram-Negative Bacteria in an Endemic Setting: Prevalence, Risk Factors, and Outcomes.

Authors:  Alexandra Vasilakopoulou; Polyxeni Karakosta; Sophia Vourli; Aikaterini Tarpatzi; Paraskevi Varda; Maria Kostoula; Anastasia Antoniadou; Spyros Pournaras
Journal:  Front Public Health       Date:  2020-03-18

6.  Tracking Antimicrobial Resistance Determinants in Diarrheal Pathogens: A Cross-Institutional Pilot Study.

Authors:  Chris R Taitt; Tomasz A Leski; Michael G Prouty; Gavin W Ford; Vireak Heang; Brent L House; Samuel Y Levin; Jennifer A Curry; Adel Mansour; Hanan El Mohammady; Momtaz Wasfy; Drake Hamilton Tilley; Michael J Gregory; Matthew R Kasper; James Regeimbal; Paul Rios; Guillermo Pimentel; Brook A Danboise; Christine E Hulseberg; Elizabeth A Odundo; Abigael N Ombogo; Erick K Cheruiyot; Cliff O Philip; Gary J Vora
Journal:  Int J Mol Sci       Date:  2020-08-18       Impact factor: 5.923

7.  Assessment of carbapenem-resistant Enterobacteriaceae-plate formula and quality control procedure.

Authors:  Thanh C Tran; Binh T Pham; Van H Pham; The A Ngo; Håkan Hanberger; Mattias Larsson; Linus Olson
Journal:  Microbiologyopen       Date:  2020-11-09       Impact factor: 3.139

8.  Maternal Vaginal Colonization and Extended-Spectrum Beta-Lactamase-Producing Bacteria in Vietnamese Pregnant Women.

Authors:  Nguyen Thanh Viet; Vu Van Du; Nghiem Duc Thuan; Hoang Van Tong; Nguyen Linh Toan; Can Van Mao; Nguyen Van Tuan; Srinivas Reddy Pallerla; Dennis Nurjadi; Thirumalaisamy P Velavan; Ho Anh Son
Journal:  Antibiotics (Basel)       Date:  2021-05-13

9.  Positivity of Carbapenemase-producing Enterobacteriaceae in Patients Following Exposure within Long-term Care Facilities in Seoul, Korea.

Authors:  Jin Ju Park; Yu Bin Seo; Jacob Lee; Joong Sik Eom; Wonkeun Song; Young Kyun Choi; Sung Ran Kim; Hee Jung Son; Nan Hyoung Cho
Journal:  J Korean Med Sci       Date:  2020-09-14       Impact factor: 2.153

10.  Factors influencing choices of empirical antibiotic treatment for bacterial infections in a scenario-based survey in Vietnam.

Authors:  Thi Lan Huong Vu; Quoc Dat Vu; Bao Long Hoang; Thi Cam Tu Nguyen; Thi Dieu Ngan Ta; Behzad Nadjm; H Rogier van Doorn
Journal:  JAC Antimicrob Resist       Date:  2020-11-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.